uniQure NV News

UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating

UBS Lowers UniQure's Price Target to $27 From $38, Maintains Buy Rating.

MT NewswiresApr 2 11:50 ET

Kyowa Kirin's Rare Disease Therapy Becomes World's Most Expensive Drug

Seeking AlphaMar 20 12:11 ET

13 Best Biotech Stocks To Buy Under $20

Yahoo FinanceMar 13 07:07 ET

AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Sec

BenzingaMar 4 07:56 ET

UniQure Is Maintained at Neutral by Mizuho

UniQure Is Maintained at Neutral by Mizuho

Dow JonesMar 4 07:22 ET

Express News | Mizuho Maintains Neutral on UniQure, Lowers Price Target to $7

Moomoo 24/7Mar 4 07:12 ET

Earnings Update: UniQure N.V. (NASDAQ:QURE) Just Reported And Analysts Are Trimming Their Forecasts

It's been a mediocre week for uniQure N.V. (NASDAQ:QURE) shareholders, with the stock dropping 12% to US$5.59 in the week since its latest full-year results. Revenues were a bright spot, with US

Simply Wall StMar 3 07:02 ET

UniQure Is Maintained at Buy by HC Wainwright & Co.

UniQure Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMar 1 14:21 ET

HC Wainwright & Co. Maintains Buy on UniQure, Lowers Price Target to $25

HC Wainwright & Co. analyst Patrick Trucchio maintains uniQure (NASDAQ:QURE) with a Buy and lowers the price target from $30 to $25.

BenzingaMar 1 14:12 ET

UniQure Cut to Neutral From Buy by Goldman Sachs

UniQure Cut to Neutral From Buy by Goldman Sachs

Dow JonesFeb 29 11:20 ET

Express News | Goldman Sachs Downgrades UniQure to Neutral, Lowers Price Target to $8

Moomoo 24/7Feb 29 11:09 ET

UniQure NV CEO Matthew Kapusta Sells 27,904 Shares

Yahoo FinanceFeb 29 09:06 ET

Recap: UniQure Q4 Earnings

uniQure (NASDAQ:QURE) reported its Q4 earnings results on Wednesday, February 28, 2024 at 07:05 AM.Here's what investors need to know about the announcement.EarningsuniQure missed estimated earnings b

BenzingaFeb 28 09:50 ET

UniQure NV (QURE) Reports 2023 Financial Results Amid Strategic Reorganization

Yahoo FinanceFeb 28 08:35 ET

UniQure GAAP EPS of -$6.47 Misses by $0.21, Revenue of $15.84M Beats by $1.04M

Seeking AlphaFeb 28 07:25 ET

12 Best Medical Stocks to Buy Under $10

Yahoo FinanceFeb 27 03:30 ET

UniQure Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

UniQure Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesJan 19 07:14 ET

Express News | RBC Capital Reiterates Outperform on UniQure, Maintains $28 Price Target

Moomoo 24/7Jan 16 09:12 ET

RBC Capital Remains a Buy on UniQure (QURE)

TipRanksJan 5 20:46 ET

Pfizer Wins Canada Approval for Hemophilia B Gene Therapy

Seeking AlphaJan 3 10:19 ET